<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43650">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02050425</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-2013-0536</org_study_id>
    <nct_id>NCT02050425</nct_id>
  </id_info>
  <brief_title>Breath Analysis in Obstructive Sleep Apnoea</brief_title>
  <official_title>Exhaled Breath Analysis by Mass Spectrometry in Patients With Obstructive Sleep Apnoea - a Randomised Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial in patients with obstructive sleep apnoea that are randomised to either
      continue or withdraw continuous positive airway pressure therapy to identify a
      disease-specific exhaled breath pattern by mass spectrometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomised placebo-controlled trial (therapeutic vs. subtherapeutic continuous positive
      airway pressure [CPAP]) including 30 OSA patients to define the effects of CPAP withdrawal
      (subtherapeutic CPAP) on the composition of exhaled breath analysed by mass spectrometry for
      identification of OSA specific markers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Exhaled breath pattern.</measure>
    <time_frame>at baseline and at follow-up (2 weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>OSA-specific mass spectrometric exhaled breath pattern.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>apnoea-hypopnoea index (AHI)</measure>
    <time_frame>at baseline and at follow-up (2 weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>measure of sleep apnoea severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxygen desaturation index (ODI), 4% dips</measure>
    <time_frame>at baseline and at follow-up (2 weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>measure of sleep apnoea severity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obstructive Sleep Apnoea (OSA)</condition>
  <arm_group>
    <arm_group_label>Therapeutic CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients continue therapeutic continuous positive airway pressure (CPAP).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subtherapeutic CPAP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo-CPAP device delivering subtherapeutic pressure for two weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo-CPAP device</intervention_name>
    <description>short-term CPAP withdrawal by the use of Placebo-CPAP</description>
    <arm_group_label>Subtherapeutic CPAP</arm_group_label>
    <other_name>subtherapeutic CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Patients continue therapeutic CPAP therapy</description>
    <arm_group_label>Therapeutic CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed OSA (at the time of original diagnosis) with an oxygen desaturation index
             (ODI) of &gt;20/h.

          -  Currently &gt;20/h oxygen desaturations (â‰¥4% dips) during an ambulatory nocturnal pulse
             oximetry performed on the last night of a 4-night period without CPAP.

          -  Treated with CPAP for more than 12 months, minimum compliance 4h/night,
             apnoea-hypopnoea index (AHI) &lt;10 with treatment (according to CPAP- download) and
             current ESS &lt;10.

          -  Age between 20 and 75 years at trial entry.

        Exclusion Criteria:

          -  Previous ventilatory failure (awake SpO2 &lt;93% and PaCO2&gt;6kPa).

          -  Unstable, untreated coronary or peripheral artery disease, severe arterial
             hypertension or hypotension  (&gt;180/110 or &lt;90/60mmHg)

          -  Previously diagnosed with Cheyne-Stokes breathing.

          -  Current professional driver; any previous sleep related accident.

          -  Acute inflammatory disease.

          -  Acute or chronic hepatic disease.

          -  Renal failure or renal replacement therapy.

          -  Use of inhaled drugs.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Malcolm Kohler, Prof. MD</last_name>
    <phone>+41442551111</phone>
    <email>malcolm.kohler@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Esther I Schwarz, MD</last_name>
    <phone>+41442551111</phone>
    <email>estherirene.schwarz@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Pulmonology, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malcolm Kohler, Prof. MD</last_name>
      <phone>+4144255111</phone>
      <email>malcolm.kohler@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Esther I Schwarz, MD</last_name>
      <phone>+4144255111</phone>
      <email>estherirene.schwarz@usz.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Malcolm Kohler, Prof. MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esther I Schwarz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 29, 2014</lastchanged_date>
  <firstreceived_date>January 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Malcolm Kohler</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>CPAP</keyword>
  <keyword>exhaled breath</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
